Found: 9
Select item for more details and to access through your institution.
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1256, doi. 10.3390/ph14121256
- By:
- Publication type:
- Article
Optimal regimens of sulfamethoxazoletrimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-016-1206-8
- By:
- Publication type:
- Article
An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
- Published in:
- Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa029
- By:
- Publication type:
- Article
No increased risk of herpes zoster in TNF inhibitor and non‐TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 9, p. 1670, doi. 10.1111/1756-185X.13300
- By:
- Publication type:
- Article
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 2, p. 241, doi. 10.1007/s10067-016-3485-5
- By:
- Publication type:
- Article
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 12, p. 3661, doi. 10.1007/s10067-022-06305-w
- By:
- Publication type:
- Article
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 1, p. 16, doi. 10.1080/14397595.2020.1869370
- By:
- Publication type:
- Article
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.
- Published in:
- Modern Rheumatology, 2017, v. 27, n. 5, p. 787, doi. 10.1080/14397595.2016.1259715
- By:
- Publication type:
- Article
High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 4, p. 522, doi. 10.3109/14397595.2015.1106682
- By:
- Publication type:
- Article